Research

Access

January 27, 2026

Do expedited FDA approvals translate to faster insurance coverage?

Access

January 12, 2026

How does non-medical switching affect patient outcomes?

A systematic review highlights its negative consequences

Access

December 23, 2025

Are employer-sponsored health plans meeting the needs of patients with chronic disease?

Access

December 23, 2025

How do patients with chronic illness experience health insurance, and what do they believe needs to change?

Access

December 23, 2025

Non-medical switching among AFib patients: Disruptions in treatment

Value

November 25, 2025

Tailoring generalized cost-effectiveness analysis (GCEA) to the U.S. setting: The importance of using the right prices

Value

November 3, 2025

Are state prescription drug affordability boards (PDABs) and upper payment limits (UPLs) achieving their intended goals?

Value

October 27, 2025

Are cost-effectiveness analysis thresholds fit for purpose for U.S. decision-making?

Access

October 9, 2025

Does the 340B Program unintentionally reinforce patterns of hospital consolidation in the United States?

Research presented at the 2025 ISPOR Conference offers a new perspective on this issue.

Access

July 18, 2025

Are 340B hospital child sites reaching underserved communities, or are they drifting away from the Program’s original intent?